Literature DB >> 1641597

Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.

A S Dofferhoff1, H J de Jong, V J Bom, J van der Meer, P C Limburg, H G de Vries-Hospers, J Marrink, P O Mulder, J Weits.   

Abstract

Sepsis or septic shock is frequently associated with activation of the complement system, coagulation and fibrinolytic changes and the release of several cytokines. In this study we analyzed the relation of complement activation to the inflammatory mediators, hemodynamic and biochemical parameters and severity of illness and outcome in 20 consecutive patients with clinically defined sepsis. Levels of C3a and C3d were elevated in 90% of the patients (median levels 0.19 mg/l and 8.6 mg/l respectively) in comparison to 14% and 42%, respectively of 7 patients with non-septic shock. Levels of C4 were decreased in only 1 of the 20 septic patients. Levels of TNF and IL-6 were elevated in 94% and 100% of the patients, Levels of TNF and IL-6 were elevated in 94% and 100% of the patients, respectively (median levels 122 ng/l and 1300 U/ml) and were clearly interrelated (r = 0.67, p less than 0.01). C3a levels correlated with the APACHE II score (r = 0.57, p less than 0.05) and high C3a levels were associated with fatal outcome (p less than 0.05). C3a was also correlated inversely with mean arterial pressure (r = 0.50, p less than 0.01). Levels of complement C3a and C3d significantly correlated with levels of plasminogen activator inhibitor-1 (PAI) and correlated inversely with AT-III levels. We found no correlation between these complement products and leukocyte counts or lactate levels, nor was there a correlation between C3a or C3d and the cytokines TNF and IL-6. Levels of C3a and C3d did not decrease significantly during the first 24 h of treatment, in contrast to a clear decrease in IL-6 levels in all patients and a decrease in TNF in the surviving patients. TNF levels remained stable or increased in the non-survivors. We conclude that both the complement system and the cytokine system are involved in the pathogenesis of septic shock and may be involved in the development of some of the fatal complications like hypotension and disseminated intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641597     DOI: 10.3109/00365549209052612

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 2.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

3.  Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings.

Authors:  Günseli Orhun; Figen Esen; Perihan Ergin Özcan; Serra Sencer; Başar Bilgiç; Canan Ulusoy; Handan Noyan; Melike Küçükerden; Achmet Ali; Mehmet Barburoğlu; Erdem Tüzün
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

4.  Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis.

Authors:  J N Hoffmann; W H Hartl; R Deppisch; E Faist; M Jochum; D Inthorn
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

5.  Posterior Reversible Encephalopathy Syndrome and Septic Encephalopathy: Neuroimaging, Inflammation and Neurodegeneration Findings.

Authors:  Günseli Orhun
Journal:  Noro Psikiyatr Ars       Date:  2019-10-09       Impact factor: 1.339

Review 6.  The role of complement system in septic shock.

Authors:  Jean Charchaflieh; Jiandong Wei; Georges Labaze; Yunfang Joan Hou; Benjamin Babarsh; Helen Stutz; Haekyung Lee; Samrat Worah; Ming Zhang
Journal:  Clin Dev Immunol       Date:  2012-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.